Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Kim, Su Mi ^a   Kim, Yang Gyun ^a   Jeong, Kyung Hwan ^b   Lee, Sang Ho ^a   Lee, Tae Won ^b   Ihm, Chun Gyoo ^b   Moon, Ju Young ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; ANGIOTENSIN 5; ANGIOTENSIN 6; ANGIOTENSIN 7; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; APOCYNIN; CYTOCHROME C; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CYTOSOLIC FRACTION; DEPOLARIZATION; KIDNEY DISEASE; KIDNEY TUBULE CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; RAT; SECOND MESSENGER; WESTERN BLOTTING;

ACETOPHENONES; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; APOPTOSIS INDUCING FACTOR; CELL SURVIVAL; CELLS, CULTURED; CYTOCHROMES C; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; KIDNEY TUBULES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NADPH OXIDASE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 84863631208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039739     Document Type: Article

References (34)

1. Ruiz-Ortega M, Bustos C, Plaza JJ, Egido J, (1998) Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. Nephrol Dial Transplant 13: 886-892.
2. Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, et al. (2005) The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10: 1139-1151.
3. Van Buul JD, Fernandez-Borja M, Anthony EC, Hordijk PL, (2005) Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7: 308-317.
4. Block K, Gorin Y, Abboud HE, (2009) Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci U S A 106: 14385-14390.
5. Ago T, Kuroda J, Pain J, Fu C, Li H, et al. (2010) Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res 106: 1253-1264.
6. Stegbauer J, Potthoff SA, Quack I, Mergia E, Clasen T, et al. (2011) Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice. Br J Pharmacol 163: 974-983.
7. Iyer SN, Yamada K, Diz DI, Ferrario CM, Chappell MC, (2000) Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J Cardiovasc Pharmacol 36: 109-117.
8. Moon JY, Tanimoto M, Gohda T, Hagiwara S, Yamazaki T, et al. (2011) Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. Am J Physiol Renal Physiol 300: F1271-1282.
9. Paravicini TM, Touyz RM, (2006) Redox signaling in hypertension. Cardiovasc Res 71: 247-258.
10. Shah SV, Baliga R, Rajapurkar M, Fonseca VA, (2007) Oxidants in chronic kidney disease. J Am Soc Nephrol 18: 16-28.
11. Geiszt M, Kopp JB, Varnai P, Leto TL, (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97: 8010-8014.
12. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, et al. (2005) Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626.
13. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, et al. (2003) Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 46: 1428-1437.
14. Zhang L, Nguyen MV, Lardy B, Jesaitis AJ, Grichine A, et al. (2011) New insight into the Nox4 subcellular localization in HEK293 cells: first monoclonal antibodies against Nox4. Biochimie 93: 457-468.
15. von Lohneysen K, Noack D, Wood MR, Friedman JS, Knaus UG, (2010) Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization. Mol Cell Biol 30: 961-975.
16. 2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation. Antioxid Redox Signal 12: 933-943.
17. Zorov DB, Juhaszova M, Yaniv Y, Nuss HB, Wang S, et al. (2009) Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res 83: 213-225.
18. Ushio-Fukai M, (2006) Localizing NADPH oxidase-derived ROS. Sci STKE 2006: re8.
19. Brown DI, Griendling KK, (2009) Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253.
20. Gwathmey TM, Pendergrass KD, Reid SD, Rose JC, Diz DI, et al. (2010) Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus. Hypertension 55: 166-171.
21. Graham S, Gorin Y, Abboud HE, Ding M, Lee DY, et al. (2011) Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am J Physiol Cell Physiol 301: C304-315.
22. Gava E, Samad-Zadeh A, Zimpelmann J, Bahramifarid N, Kitten GT, et al. (2009) Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells. Nephrol Dial Transplant 24: 1766-1773.
23. Gallagher PE, Ferrario CM, Tallant EA, (2008) MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. Am J Physiol Cell Physiol 295: C1169-1174.
24. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI, (1997) Counterregulatory actions of angiotensin-(1-7). Hypertension 30: 535-541.
25. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, et al. (1995) Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 25: 796-802.
26. Nakamura S, Averill DB, Chappell MC, Diz DI, Brosnihan KB, et al. (2003) Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. Am J Physiol Regul Integr Comp Physiol 284: R164-173.
27. Wysocki J, Ye M, Rodriguez E, Gonzalez-Pacheco FR, Barrios C, et al. (2010) Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension 55: 90-98.
28. Irani K, (2000) Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87: 179-183.
29. Hampton MB, Fadeel B, Orrenius S, (1998) Redox regulation of the caspases during apoptosis. Ann N Y Acad Sci 854: 328-335.
30. Hampton MB, Orrenius S, (1997) Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414: 552-556.
31. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, et al. (2006) Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 26: 333-339.
32. Simons JM, Hart BA, Ip Vai Ching TR, Van Dijk H, Labadie RP, (1990) Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med 8: 251-258.
33. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, et al. (2008) Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28: 25-33.
34. Liao XX, Guo RX, Ma H, Wang LC, Chen ZH, et al. (2008) Effects of angiotensin-(1-7) on oxidative stress and functional changes of isolated rat hearts induced by ischemia-reperfusion. Nan Fang Yi Ke Da Xue Xue Bao 28: 1345-1348.